StockTipsArenaBeta

SELL Sudeep Pharma Limited — Prabhudas Lilladher

SELLSudeep Pharma Limited
Sudeep Pharma share price target & all analyst calls

byPrabhudas LilladherHorizon: NA (inferred 1–3 months)27 Aug 2026via Economic Times New Stock Recos

Entry₹1,134.1Inferred
Target₹855
Total upside +24.61%
Stop lossNot given
CMP₹966.22d ago
Active+14.80%+11.51%upside left 5 wk left
Follow Prabhudas Lilladher for new calls(40% target hit, 10 closed calls)Get alertsWatch SUDEEPPHRM for new buy/sell callsGet alertsSee 39 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 10:51 pm IST
2 supporting3 neutral2 opposing
Supports the SELL call (2)

MACD below its signal line — bearish momentum

Technicals · macd·25 Oct · today

Mr. Sendhil Pani has ceased to be the Managing Director of Sudeep Pharma due to the completion of his contractual arrangement.

BSE · Company Update·5 Oct · 3w ago

(opens in new tab)
Neutral / worth noting (3)

Q2 FY27 results scheduled — board meets 28 Oct 2026

BSE · Board Meeting·In 2 days

(opens in new tab)

This small-cap stock surged 75% since IPO price but ICICI Securities sets target below CMP; what should shareholders do?

NewsLivemint·14 Oct · 2w ago

(opens in new tab)
Weighs against the SELL call (2)

RSI at 17 — oversold territory

Technicals · rsi·25 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sudeep Pharma

All analyst calls on Sudeep Pharma

More from Prabhudas Lilladher

Every call and its outcome